We have the experience and resources to help you analyze your PET opportunity and assure a successful transition adding cardiac PET to your practice. We are focused on redefining the term turn-key to incorporate a more comprehensive approach to practice excellence. Our solutions factor in people and processes, efficient workflows, practice analytics and unparalleled clinical expertise to support the present and future.
With over 25 nuclear SPECT and PET labs nationwide, Molecular Imaging Services, Inc. brings access to a solid network of reliable support in the ever-changing areas of corporate compliance, regulatory, political and economic factors that affect our practices and the industry. Meet the team that is nationally recognized as the most experienced professionals in cardiac PET.
A fifty-one year old female patient was referred for SPECT Imaging due to intermittent chest pain. The symptoms were considered atypical and not accelerating...
The patient underwent a pharmacologic rest/stress PET study (5 mSv) with no symptoms or ECG changes.
The PET study demonstrated completely normal perfusion and function with a similar ejection fraction (58%) to the SPECT study Figure B.
